Considerations on combination therapies for disease modification in Parkinson's.
Saved in:
| Title: | Considerations on combination therapies for disease modification in Parkinson's. |
|---|---|
| Authors: | Hughes RM; Cure Parkinson's, London, UK. rachel.hughes@cureparkinsons.org.uk., Pilcicka A; Cure Parkinson's, London, UK., Klee T; Highway Pharmaceuticals, Boston, MA, USA., Ducotterd F; Alzheimer's Research UK UCL Drug Discovery Institute, University College London, London, UK., Mortiboys H; Sheffield Institute for Translational Neuroscience (SITraN), School of Medicine and Population Health, University of Sheffield, Sheffield, UK., Stott SRW; Cure Parkinson's, London, UK. |
| Source: | NPJ Parkinson's disease [NPJ Parkinsons Dis] 2026 Jul 17; Vol. 12 (1). Date of Electronic Publication: 2026 Jul 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101675390 Publication Model: Electronic Cited Medium: Print ISSN: 2373-8057 (Print) Linking ISSN: 23738057 NLM ISO Abbreviation: NPJ Parkinsons Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2373-8057 |
|---|---|
| DOI: | 10.1038/s41531-026-01483-9 |
